Renewal has occurred in the use of plant sterols for the treatment of hyper
cholesterolemias. A novel development was to convert plant sterols to corre
sponding stanols and esterify them to fat soluble form. In contrast to the
crystalline plant sterols or stanols, plant stanol esters can be easily con
sumed during normal food intake in soluble form in different fat-containing
food constituents when they have a potent cholesterol-lowering effect, sho
wn in normo- and hypercholesterolemic men and women without or with coronar
y heart disease, children and diabetes. Cholesterol lowering is approximate
ly 10% for total and 15% for LDL cholesterol, with the respective values fo
r stanol ester margarine (2-3 g/day stanols) being 15% and 20%. Stanol este
rs reduce cholesterol absorption efficiency by up to 65%, increase choleste
rol elimination in feces as cholesterol itself, usually not as bile acids,
and stimulate cholesterol synthesis. Serum beta-carotene level is lowered,
but no fat malabsorption or lowering of serum fat soluble vitamins have bee
n observed. In contrast to plant sterols, stanols and their esters are mini
mally absorbed and they reduce serum plant sterol concentrations, also prev
enting statin-induced increase of plant sterols. Stanol ester margarine has
been included in dietary treatment of hypercholesterolemia followed by the
addition of drug treatment in resistant cases. Curr Opin Lipidol 10:9-14.
(C) 1999 Lippincott Williams & Wilkins.